Skip to main content

Table 7 Predictivity of clinical response by different biomarkers or in vitro chemosensitivity test

From: Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy

 

Sensitivity (%)

Resistance (%)

p

Markers

   

   MGMT

75.0

72.5

0.03

   XPD

37.5

90.9

0.06

   Five markers

33.3

100

0.07

Chemosensitivity test

85.7

91.3

0.0003